The dopamine D2 receptor gene TaqI A polymorphism is not associated with Novelty Seeking, Harm Avoidance and Reward Dependence in healthy subjects

By de Brettes B.   Berlin I.   Laurent C.   Lepine J.   Mallet J.   Puech A.  

European Psychiatry, Vol. 13, Iss. 8, 1998-12 ,pp. : 427-430

Elsevier

Access to resources Recommend Favorite

Dopamine D2 Receptors in the Insular Cortex and the Personality Trait of Novelty Seeking

By Suhara T.   Yasuno F.   Sudo Y.   Yamamoto M.   Inoue M.   Okubo Y.   Suzuki K.  

NeuroImage, Vol. 13, Iss. 5, 2001-05 ,pp. : 891-895

Academic Press

Access to resources Recommend Favorite

Dopamine agonists and valvular heart disease in patients with Parkinson's disease: evidence and mystery

By Yamamoto Mitsutoshi   Uesugi Tadahisa  

Journal of Neurology, Vol. 254, Iss. 5, 2007-09 ,pp. : 74-78

Springer Publishing Company

Access to resources Recommend Favorite

Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists

By Roth T.   Rye D.B.   Borchert L.D.   Bartlett C.   Bliwise D.L.   Cantor C.   Gorell J.M.   Hubble J.P.   Musch B.   Olanow C.W.   Pollak C.   Stern M.B.   Watts R.L.  

Sleep Medicine, Vol. 4, Iss. 4, 2003-07 ,pp. : 275-280

Elsevier

Access to resources Recommend Favorite

Usefulness of switching to cabergoline from other dopamine agonists in patients with advanced Parkinson’s disease

By Shiraishi M.   Kamo T.   Hotta M.   Nemoto S.   Oshima J.   Sugihara H.   Yasaki S.   Kawakami M.   Takahashi Y.   Shimojo S.  

Journal of Neural Transmission, Vol. 111, Iss. 6, 2004-06 ,pp. : 725-732

Springer Publishing Company

Access to resources Recommend Favorite